Nordea Investment Management Ab Vir Biotechnology, Inc. Transaction History

Nordea Investment Management Ab

$92.4 Billion
Q4 2024

A detailed history of Nordea Investment Management Ab transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Nordea Investment Management Ab holds 136,487 shares of VIR stock, worth $1.44 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

136,487

Previous 423,087 67.74%

Holding current value

$1.44 Million

Previous $3.17 Million 68.4%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 06, 2025	SELL	$6.74 - $10.17 $1.93 Million - $2.91 Million	-286,600 Reduced 67.74%	136,487 $1 Million
Q3 2024 Nov 05, 2024	BUY	$7.26 - $10.7 $1.07 Million - $1.58 Million	147,552 Added 53.55%	423,087 $3.17 Million
Q2 2024 Aug 08, 2024	BUY	$7.63 - $12.66 $304,215 - $504,766	39,871 Added 16.92%	275,535 $2.45 Million
Q1 2024 May 02, 2024	BUY	$8.6 - $11.9 $749,834 - $1.04 Million	87,190 Added 58.72%	235,664 $2.39 Million
Q4 2023 Jan 10, 2024	SELL	$7.76 - $10.29 $20,851 - $27,649	-2,687 Reduced 1.78%	148,474 $1.49 Million
Q3 2023 Nov 13, 2023	SELL	$9.14 - $24.62 $13,856 - $37,323	-1,516 Reduced 0.99%	151,161 $1.42 Million
Q2 2023 Jul 07, 2023	BUY	$23.2 - $27.29 $79,228 - $93,195	3,415 Added 2.29%	152,677 $3.75 Million
Q1 2023 Apr 19, 2023	SELL	$22.26 - $30.85 $107,582 - $149,098	-4,833 Reduced 3.14%	149,262 $3.47 Million
Q4 2022 Feb 08, 2023	BUY	$19.96 - $28.22 $12,674 - $17,919	635 Added 0.41%	154,095 $3.9 Million
Q3 2022 Oct 19, 2022	SELL	$18.26 - $31.1 $10,189 - $17,353	-558 Reduced 0.36%	153,460 $2.98 Million
Q2 2022 Aug 09, 2022	BUY	$19.08 - $26.7 $47,375 - $66,296	2,483 Added 1.64%	154,018 $3.91 Million
Q1 2022 Apr 11, 2022	BUY	$21.19 - $40.01 $53,186 - $100,425	2,510 Added 1.68%	151,535 $3.99 Million
Q4 2021 Jan 20, 2022	BUY	$30.97 - $54.03 $4.33 Million - $7.55 Million	139,722 Added 1501.9%	149,025 $6.21 Million
Q3 2021 Nov 01, 2021	SELL	$34.9 - $54.54 $324,674 - $507,385	-9,303 Reduced 50.0%	9,303 $414,000
Q3 2021 Nov 01, 2021	BUY	$34.9 - $54.54 $649,349 - $1.01 Million	18,606 New	18,606 $809,000

Others Institutions Holding VIR

# of Institutions

214

Shares Held

86.6M

Call Options Held

127K

Put Options Held

1.19M

View Full List

About Vir Biotechnology, Inc.

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $1.4B
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

More about VIR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nordea Investment Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Nordea Investment Management Ab with notifications on news.

Account

Nordea Investment Management Ab Vir Biotechnology, Inc. Transaction History